Cargando…
Therapeutic trials in difficult to treat steroid sensitive nephrotic syndrome: challenges and future directions
Steroid sensitive nephrotic syndrome is a common condition in pediatric nephrology, and most children have excellent outcomes. Yet, 50% of children will require steroid-sparing agents due to frequently relapsing disease and may suffer consequences from steroid dependence or use of steroid-sparing ag...
Autores principales: | McKay, Ashlene M., Parekh, Rulan S., Noone, Damien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048617/ https://www.ncbi.nlm.nih.gov/pubmed/35482099 http://dx.doi.org/10.1007/s00467-022-05520-6 |
Ejemplares similares
-
Ethnic Differences in Childhood Nephrotic Syndrome
por: Chanchlani, Rahul, et al.
Publicado: (2016) -
Efficacy of rituximab versus tacrolimus in difficult-to-treat steroid-sensitive nephrotic syndrome: an open-label pilot randomized controlled trial
por: Mathew, Georgie, et al.
Publicado: (2022) -
Common Risk Variants in AHI1 Are Associated With Childhood Steroid Sensitive Nephrotic Syndrome
por: Downie, Mallory L., et al.
Publicado: (2023) -
Steroid Sensitive Nephrotic Syndrome: Revised Guidelines
por: Sinha, Aditi, et al.
Publicado: (2021) -
Intravenous cyclophosphamide induces remission in children with difficult to treat steroid resistant nephrotic syndrome from minimal change disease
por: Haddad, Maha, et al.
Publicado: (2021)